Mumbai : The youngest brother of Sohrabuddin Shaikh, Nayamuddin, claimed before a special CBI court on Monday that the CBI, on its own, added to his statement recorded in 2010 by a CBI official, the names of Gujarat police officer Abhay Chudasama and BJP president Amit Shah.
Nayamuddin, who was to appear as the first prosecution witness in the case on November 29, 2017, came before the court after multiple summons and a non-bailable warrant were issued against him. He also orally requested the court to take an FIR against the CBI and against witnesses who have turned hostile in the case. He claimed that the CBI had “spoilt” the case.
After his deposition narrating the sequence of events in November 2005, when his brother was allegedly killed in a fake encounter, Nayamuddin’s examination-in-chief was declared to be over by special public prosecutor, BP Raju.
Nayamuddin, however, said there was more in his statement which he wanted to talk about. “I have no threat from the BJP. I have never heard Azam Khan’s name. An investigating officer of the CBI, Dagar sahab, came to my village in an autorickshaw to inquire about this case. I have not said before him that Azam (Sohrabuddin’s associate and co-accused in Hamid Lala murder case) met me and said that Abhay Chudasama offered Rs 50 lakh to withdraw a petition filed in Supreme Court to inquire into the death of my brother,” Nayamuddin told the court. He also said that he had given a handwritten affidavit before the special court in Ahmedabad clarifying that he had never said the things attributed to him in his 2010 statement.
According to the chargesheet filed by the CBI, Nayamuddin had given a statement on February 19, 2010, recorded by officer DS Dagar, a deputy superintendent of police, CBI. The statement claims that Chudasama, discharged from the case in 2015, had called Nayamuddin and threatened him.
“When I told him (Chudasama) that we will not withdraw the petition at any cost, he threatened me with dire consequences and said that I would also face the same fate as Sohrabuddin. You do not know Amitbhai is very angry. I will speak to Amitbhai and he can get it done in Madhya Pradesh only. It is Amitbhai’s government there and you will be killed for making him a party in the petition,” Nayamuddin’s statement cited in the CBI’s chargesheeet stated.
Nayamuddin on Monday said that this part was added by the CBI on its own.
courtesy : indianexpress.com
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
New Delhi (PTI): The Food Safety and Standards Authority of India (FSSAI) has categorically dismissed recent claims linking eggs to cancer risk, terming them "misleading, scientifically unsupported and capable of creating unnecessary public alarm".
In a statement issued on Saturday, the food safety regulator clarified that eggs available in the country are safe for human consumption and that reports alleging the presence of carcinogenic substances in eggs lack a scientific basis.
The clarification comes in response to media reports and social media posts claiming detection of nitrofuran metabolites (AOZ) -- substances purportedly linked to cancer -- in eggs sold in India.
FSSAI officials emphasised that the use of nitrofurans is strictly prohibited at all stages of poultry and egg production under the Food Safety and Standards (Contaminants, Toxins and Residues) Regulations, 2011.
The regulator explained that an Extraneous Maximum Residue Limit (EMRL) of 1.0 µg/kg has been prescribed for nitrofuran metabolites -- but solely for regulatory enforcement purposes. This limit represents the minimum level that can be reliably detected by advanced laboratory methods and does not indicate that the substance is permitted for use.
"Detection of trace residues below the EMRL does not constitute a food safety violation nor does it imply any health risk," an FSSAI official said.
FSSAI said India's regulatory framework is aligned with international practices. The European Union and the United States also prohibit the use of nitrofurans in food-producing animals and employ reference points for action or guideline values only as enforcement tools.
Differences in numerical benchmarks across countries reflect variations in analytical and regulatory approaches, not differences in consumer safety standards, the authority noted.
On public health concerns, FSSAI cited scientific evidence indicating that there is no established causal link between trace-level dietary exposure to nitrofuran metabolites and cancer or other adverse health outcomes in humans.
"No national or international health authority has associated normal egg consumption with increased cancer risk," the regulator reiterated.
Addressing reports related to the testing of a specific egg brand, officials explained that such detections are isolated and batch-specific, often arising from inadvertent contamination or feed-related factors, and are not representative of the overall egg supply chain in the country.
"Generalising isolated laboratory findings to label eggs as unsafe is scientifically incorrect," the statement said.
FSSAI urged consumers to rely on verified scientific evidence and official advisories, reiterating that eggs remain a safe, nutritious, and valuable component of a balanced diet when produced and consumed in compliance with food safety regulations.
